Arch Therapeutics, Inc. Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Arch Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • Arch Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $592K, a 6.74% decline year-over-year.
  • Arch Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $3.72M, a 126% increase year-over-year.
  • Arch Therapeutics, Inc. annual Interest Expense for 2023 was $3.1M, a 446% increase from 2022.
  • Arch Therapeutics, Inc. annual Interest Expense for 2022 was $567K, a 277% increase from 2021.
  • Arch Therapeutics, Inc. annual Interest Expense for 2021 was $151K, a 712% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.1M +$2.53M +446% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 $567K +$417K +277% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 $151K +$132K +712% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
2020 $18.5K Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2018 $0 -$52.4K -100% Oct 1, 2017 Sep 30, 2018 10-K 2018-12-18
2017 $52.4K -$224K -81.1% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
2016 $277K -$101K -26.8% Oct 1, 2015 Sep 30, 2016 10-K 2017-11-15
2015 $378K +$267K +240% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-05
2014 $111K +$2.18K +2% Oct 1, 2013 Sep 30, 2014 10-K 2015-12-11
2013 $109K -$48K -30.6% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-12
2012 $157K Oct 1, 2011 Sep 30, 2012 10-K/A 2014-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.